# Lineage Cell Therapeutics, Inc.: Form 8-K, filed Mar 11, 2026

- Company: [Lineage Cell Therapeutics, Inc.](/companies/lctx.md) (CIK 876343)
- Form: 8-K
- Filed: 2026-03-11
- Accepted by EDGAR: Mar 11, 2026, 09:00 ET
- Period: 2026-03-11
- Accession: 0001193125-26-101167
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/876343/000119312526101167/lctx-20260311.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/876343/000119312526101167/

## Items reported

- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/876343/000119312526101167/lctx-20260311.htm

Filed Mar 11, 2026.
Source: SEC EDGAR, the filing index for accession 0001193125-26-101167. Last ingested by Listed: Oct 24, 2026, 14:58 ET. No prices; not investment advice.